Diuretic Injection Franchise in Ahmedabad

Furosemide Injection Supplier in Mumbai

Cardiac Injection Distributor in Delhi

Furosemide Injection Manufacturer in Bangalore

Edema Injection Stockist in Hyderabad
Diuretic Injection Exporter in Chandigarh

Home/Products /frusemide-i-p-20-mg-injection

Furotide 10 Injection

Composition : Furosemide (10mg/ml) Injection

Dosage Form : Injection

Packaging Type : Vial

Packaging : 10x2ml

Price : ₹0/-

Furotide 10 Injection containing Furosemide 10 mg/ml is a potent diuretic used for rapid removal of excess fluid from the body. It helps in managing edema, controlling blood pressure, and relieving symptoms associated with fluid overload in cardiac, renal, and hepatic conditions.

Furosemide works by acting on the kidneys to increase urine output, promoting the excretion of sodium, chloride, and water. This mechanism helps reduce fluid accumulation and lowers pressure on the heart and blood vessels.

The injection provides quick and effective action, making it suitable for emergency and hospital settings where immediate diuresis is required. It is widely used in conditions such as pulmonary edema and acute heart failure.

With increasing cases of cardiovascular and renal disorders, this product has strong demand in hospital and critical care segments. Its rapid action, high clinical utility, and consistent usage make it a valuable addition for expanding presence and driving growth in the cardiac care range.

Read More

About the Product

Furotide 10 Injection containing Furosemide 10 mg/ml is a potent diuretic used for rapid removal of excess fluid from the body. It helps in managing edema, controlling blood pressure, and relieving symptoms associated with fluid overload in cardiac, renal, and hepatic conditions.

Furosemide works by acting on the kidneys to increase urine output, promoting the excretion of sodium, chloride, and water. This mechanism helps reduce fluid accumulation and lowers pressure on the heart and blood vessels.

The injection provides quick and effective action, making it suitable for emergency and hospital settings where immediate diuresis is required. It is widely used in conditions such as pulmonary edema and acute heart failure.

With increasing cases of cardiovascular and renal disorders, this product has strong demand in hospital and critical care segments. Its rapid action, high clinical utility, and consistent usage make it a valuable addition for expanding presence and driving growth in the cardiac care range.

Some patients may experience dehydration, electrolyte imbalance (such as low potassium), dizziness, hypotension, or increased urination. Rarely, hearing disturbances, severe electrolyte imbalance, or allergic reactions may occur and require immediate medical attention.

Furotide 10 Injection is indicated for the treatment of edema associated with congestive heart failure, liver cirrhosis, and kidney disorders. It is also used in the management of acute pulmonary edema and hypertension. It helps remove excess fluid, relieve swelling, and improve breathing and overall cardiovascular function.

This injection should be administered under strict medical supervision. Monitoring of electrolyte levels, kidney function, and blood pressure is essential during treatment. Patients should be cautious about dehydration and maintain adequate fluid intake as advised by their healthcare provider.

Store in a cool, dry place below 25°C, protected from light. Do not freeze. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation